热门新闻
The National Medical Products Administration approved the IND of Sino-US Group's NK immune cell new drug, opening a new era of tumor treatment
Recently, the official website of the Center for Drug Evaluation (CDE) of the National Medi...
Good news: New hope for solid tumor treatment: "Off-the-shelf NK cell therapy for pan-malignant solid tumors" approved for IND
On March 28, 2025, according to the official website of CDE, the ZMPB-NK006 injection of ...
The world's first super-targeted immune cell PM-NKT compound cell technology
The American Saiojin Group, the University of Southern California, and the Harvard, Yale an...
PM-NKT cells precisely target and prevent the top ten difficult diseases in the human body
Cardiovascular disease: the leading cause of death in the world, with a mortality rate of up to 50%...
Super targeted progenitor cell PM-NKT composite cell technology NKT natural lineage cell immunotherapy
Promote cell regeneration, remove aging cells, kill six major cell diseases naturally.Strong immun...